Non-invasive convective head cooling during stroke thrombectomy: A prospective multi-center feasibility trial
Open Access
- 1 January 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Abstract
Introduction: Non-invasive convective head cooling is a promising putative neuroprotective therapy for ischemic stroke patients as it may portably, non-invasively, and selectively cool the ischemic penumbra. We aimed to investigate the feasibility of utilizing non-invasive convective head cooling in ischemic stroke patients before and during endovascular thrombectomy (EVT). Patients and methods: We conducted a multi-center, prospective, non-randomized, open-label trial at two comprehensive stroke centers in ischemic stroke patients where EVT was planned. Patients were assessed for eligibility in the emergency department (ED) and had a cooling cap fitted that circulated coolant between −5°C and 0°C until EVT completion. The primary feasibility endpoint was adherence, defined as tolerating cooling for ⩾50% of the time from cooling cap application until EVT completion. Results: Between July and November 2024, 40 EVT patients (19 (47.5%) female, mean ± SD age 71.6 ± 12.6 years) underwent a median (IQR) duration of convective head cooling of 86 (58–106) min. Thirty-nine (97.5%) participants met the primary feasibility endpoint. The enrollment rate was five participants per site per month. Median (IQR) time from comprehensive stroke center arrival to cooling start was 10 (5–51) min. Thirty-two (80%) patients received general anesthesia. eTICI 2b-3 reperfusion was achieved in 38 (95.0%) participants. Median (IQR) 24-h infarct volume was 14.3 (5.5–29.1) mL. Median (IQR) 3-month modified Rankin Scale score was 2 (1–5). Three-month mortality occurred in 8/38 (21.1%) participants. Nine serious adverse events occurred in 8 (20.0%) participants, none of which were attributed to head cooling. Conclusions: Convective head cooling is feasible in patients undergoing EVT and warrants further investigation in larger randomized controlled trials.Keywords
Funding Information
- Neurological Foundation of New Zealand (2324 PRG)
This publication has 32 references indexed in Scilit:
- Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trialThe Lancet, 2025
- Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra‐arterial nimodipine might be associated with worse outcomesEuropean Journal of Neurology, 2024
- Therapeutic hypothermia in patients after cardiac arrest: A systematic review and meta-analysis of randomized controlled trialsThe American Journal of Emergency Medicine, 2023
- Endovascular Therapeutic Hypothermia for Acute Ischemic Stroke: ICTuS 2/3 ProtocolInternational Journal of Stroke, 2013
- Therapeutic Hypothermia for Acute Ischemic Stroke: Ready to Start Large Randomized Trials?Journal of Cerebral Blood Flow & Metabolism, 2010
- Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysisBrain, 2007
- Noninvasive selective brain cooling by head and neck cooling is protective in severe traumatic brain injuryJournal of Clinical Neuroscience, 2006
- Differential interhemispheric cooling and ICP compartmentalization in a patient with left ICA occlusionActa Neurochirurgica, 2006
- Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trialThe Lancet, 2005
- Thermoregulation, mild perioperative hypothermia and post-anaesthetic shiveringBritish Journal of Anaesthesia, 2000